About [5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone
[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone (PubChem CID 163917843) has the molecular formula C76H88N20O4
and a molecular weight of 1345.68 g/mol. Its IUPAC name is [5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone.
Frequently Asked Questions
What is the IUPAC name of [5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone?
The IUPAC name of [5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone (CID 163917843) is [5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone.
What is the SMILES notation for [5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone?
The canonical SMILES for [5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone is Cc1[nH]ncc1-c1nc2ccc3[nH]nc(C(=O)N4CCC(N5CCN(C)CC5)CC4)c3c2c2c1CCCC2.Cc1[nH]ncc1-c1nc2ccc3[nH]nc(C(=O)N4CCCCC4)c3c2c2c1CCCC2.Cc1[nH]ncc1/C(=N/c1ccc2[nH]nc(C(=O)N3CCOCC3)c2c1)C1=CCCCC1.
What is the InChIKey of [5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone?
The InChIKey is QXUODNXPBCHEAV-WRBLFMFUSA-N. The full InChI is InChI=1S/C29H36N8O.C24H26N6O.C23H26N6O2/c1-18-22(17-30-32-18)27-21-6-4-3-5-20(21)25-23(31-27)7-8-24-26(25)28(34-33-24)29(38)37-11-9-19(10-12-37)36-15-13-35(2)14-16-36;1-14-17(13-25-27-14)22-16-8-4-3-7-15(16)20-18(26-22)9-10-19-21(20)23(29-28-19)24(31)30-11-5-2-6-12-30;1-15-19(14-24-26-15)21(16-5-3-2-4-6-16)25-17-7-8-20-18(13-17)22(28-27-20)23(30)29-9-11-31-12-10-29/h7-8,17,19H,3-6,9-16H2,1-2H3,(H,30,32)(H,33,34);9-10,13H,2-8,11-12H2,1H3,(H,25,27)(H,28,29);5,7-8,13-14H,2-4,6,9-12H2,1H3,(H,24,26)(H,27,28)/b;;25-21+.
What are the key properties of [5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone?
[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone has a molecular weight of 1345.68 g/mol, XLogP of 11.54, 9 rotatable bonds, 6 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for [5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-morpholin-4-ylmethanone;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]-piperidin-1-ylmethanone is sourced from PubChem (CID 163917843), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).